---
title: "Fentanyl dabbing with cannabis retail equipment: prevalence, practices, and clinical signals"
id: "medrxiv-8-fentanyl-dabbing-with-cannabis-retail-equipment-an-ethnographic-and-drug"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-8-fentanyl-dabbing-with-cannabis-retail-equipment-an-ethnographic-and-drug"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.13.26367858v1?rss=1"
published_at: "2026-11-16T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Fentanyl dabbing with cannabis retail equipment: prevalence, practices, and clinical signals
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-8-fentanyl-dabbing-with-cannabis-retail-equipment-an-ethnographic-and-drug
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.13.26367858v1?rss=1)
- **Published At:** 2026-11-16T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study combined ethnographic observation and interviews (California and Oregon, 2024–2026) with survey data from a Los Angeles drug checking program to characterize vaporizing fentanyl using cannabis retail equipment. - Among 108 participants who reported a route of administration, 104 (96%) reported **smoking**; among 93 who named a smoking method, 81 (87%) reported **dabbing**. - Dabbing occurred in 250 of 405 (62%) encounters where route was specified; all 11 participants who initially named another smoking method reported dabbing on later follow-up. - Field teams observed adaptation of **cannabis** retail equipment to vaporize fentanyl, and recorded physical injuries including burns associated with dabbing. - Participants described perceived benefits: discretion, lower stigma, convenience, and ability to take larger, faster inhalations; they also reported rapid tolerance development and concerns that dabbing consumed fentanyl more quickly. - Some people who had previously injected opioids said dabbing approximated the injection-associated “rush.” - The authors reported that dabbing was the dominant route among people using drug checking services in Los Angeles and was observed in every other city where fieldwork occurred. - The data source did not report specific dosing, quantitative toxicology values, or demographic breakdowns beyond geographic sites; those details were not provided in the preprint. - The authors recommend that clinicians and harm-reduction programs ask specifically about smoking methods (not just smoking vs injecting), since dabbing may shift risk profiles—reducing some harms while introducing others. - The study received institutional review board approvals and was supported by the CDC; drug checking individual-level data are not publicly available to protect confidentiality.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=ObOscr6Ig.siz4Bhsw_Ijfr3_OUC_2jgPMIod0Au.AQ-1794866012.1652784-1.2.1.1-oCvFV4db9xs5WTfW01RfDmL3Txz9Rv_NTBvI40Awe2Nv_YvHg3f7IIK5HxkrusSM) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.13.26367858v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Fentanyl dabbing with cannabis retail equipment: an ethnographic and drug-checking study Morgan Godvin, Levi Cecil, [ View ORCID Profile](http://orcid.org/0000-0001-5984-2577)Adam Koncsol, [ View ORCID Profile](http://orcid.org/0009-0000-4795-116X)Caitlin A. Molina, [ View ORCID Profile](http://orcid.org/0000-0002-6699-2992)Megan Grabill, [ View ORCID Profile](http://orcid.org/0000-0002-7977-2585)Ruby Romero, Elham Jalayer, Naomi Villanueva, Oscar Arellano, Amanda Cowan, Russell G. Buhr, Honora Englander, Joseph R. Friedman, Philippe Bourgois, [ View ORCID Profile](http://orcid.org/0000-0002-0728-4101)Chelsea L. Shover doi: https://doi.org/10.64898/2026.11.13.26367858 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Morgan Godvin 1 Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Morgan%2BGodvin%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Godvin%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMorgan%2BGodvin%2B) * For correspondence: morgangodvin@gmail.com Levi Cecil 1 Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Levi%2BCecil%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Cecil%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALevi%2BCecil%2B) Adam Koncsol 1 Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Adam%2BKoncsol%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Koncsol%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAdam%2BKoncsol%2B) * [ORCID record for Adam Koncsol](http://orcid.org/0000-0001-5984-2577 "Open in new tab") Caitlin A. Molina 1 Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Caitlin%2BA.%2BMolina%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Molina%20CA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ACaitlin%2BA.%2BMolina%2B) * [ORCID record for Caitlin A. Molina](http://orcid.org/0009-0000-4795-116X "Open in new tab") Megan Grabill 1 Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Megan%2BGrabill%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Grabill%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMegan%2BGrabill%2B) * [ORCID record for Megan Grabill](http://orcid.org/0000-0002-6699-2992 "Open in new tab") Ruby Romero 1 Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ruby%2BRomero%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Romero%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARuby%2BRomero%2B) * [ORCID record for Ruby Romero](http://orcid.org/0000-0002-7977-2585 "Open in new tab") Elham Jalayer 2 Bienestar Human Services, Los Angeles, CA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Elham%2BJalayer%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Jalayer%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AElham%2BJalayer%2B) Naomi Villanueva 2 Bienestar Human Services, Los Angeles, CA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Naomi%2BVillanueva%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Villanueva%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANaomi%2BVillanueva%2B) Oscar Arellano 3 Homeless Outreach Program Integrated Care System (HOPICS), Special Service for Groups, Los Angeles, CA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Oscar%2BArellano%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Arellano%20O&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AOscar%2BArellano%2B) Amanda Cowan 4 Community Health Project Los Angeles, Los Angeles, CA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Amanda%2BCowan%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Cowan%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAmanda%2BCowan%2B) Russell G. Buhr 5 Division of Pulmonary, Critical Care, and Sleep Medicine, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Russell%2BG.%2BBuhr%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Buhr%20RG&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARussell%2BG.%2BBuhr%2B) Honora Englander 6 Section of Addiction Medicine, Division of General Internal Medicine & Geriatrics, Department of Medicine, Oregon Health & Science University, Portland, OR, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Honora%2BEnglander%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Englander%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHonora%2BEnglander%2B) Joseph R. Friedman 7 Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Joseph%2BR.%2BFriedman%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Friedman%20JR&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJoseph%2BR.%2BFriedman%2B) Philippe Bourgois 8 Department of Anthropology and Center for Social Medicine and Humanities, University of California, Los Angeles, Los Angeles, CA, USA * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Philippe%2BBourgois%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Bourgois%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APhilippe%2BBourgois%2B) Chelsea L. Shover 1 Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Chelsea%2BL.%2BShover%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Shover%20CL&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AChelsea%2BL.%2BShover%2B) * [ORCID record for Chelsea L. Shover](http://orcid.org/0000-0002-0728-4101 "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.13.26367858v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1346424/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.13.26367858v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1346424/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.13.26367858v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1346424/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.13.26367858v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1346424/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.13.26367858v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1346424/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background: Fentanyl's entrenchment in U.S. West Coast drug markets brought a shift from injecting to smoking illicit opioids. We characterize the next transition: the rise of 'dabbing,' vaporizing fentanyl with equipment sold for cannabis concentrates. Methods: This mixed-methods study combined ethnographic interviewing and participant observation among people who use fentanyl in California and Oregon (2024-2026) with survey data from a Los Angeles drug checking program. After identifying dabbing ethnographically, we added an optional smoking-method item to the survey. Results: Of 108 participants who stated a route of administration, 104 (96%) reported smoking; of 93 who named a smoking method, 81 (87%) reported dabbing. All 11 who first named another method and returned later then reported dabbing. Dabbing was reported at 250 of 405 (62%) encounters with a stated route. We observed participants adapting cannabis equipment. They praised dabbing's discretion, reduced stigma, and convenience, and its capacity for more large hits, more quickly; the same speed led some to call it wasteful, because it went through their fentanyl faster than other methods. Participants described rapidly rising tolerance and frequent dabbing-related burns, which we also observed. Some who had injected said dabbing approximated its "rush." Conclusions: Dabbing has become the dominant way to consume fentanyl among people using drug checking services in Los Angeles, and was observed in every other city where we did fieldwork. Clinicians and programs should ask people how they smoke fentanyl, not only whether they smoke or inject; dabbing may reduce some risks while increasing others. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Institutional Review Board of the University of California, Los Angeles approved the ethnographic work (IRB-21-0901) and the quantitative and drug checking methodologies (IRB-22-0760 and IRB-22-1273). Some aspects of the work were considered exempt from review as public health surveillance. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability Drug checking data about individuals is not publicly available in order to protect confidentiality, though drug checking results data are posted online. ## Funder Information Declared Centers for Disease Control and Prevention Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.13.26367858v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.16.26368015v1 "Adrenergic nerve fibers are depleted in adenomyosis myometrium")[Next ](https://www.medrxiv.org/content/10.1101/2025.10.12.25337819v2 "Intraoperative arterial blood pressure waveform morphology variability is associated with acute kidney injury after cardiac surgery") Posted November 16, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.13.26367858v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/16/2026.11.13.26367858.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.13.26367858v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/16/2026.11.13.26367858.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Fentanyl dabbing with cannabis retail equipment: an ethnographic and drug-checking study Morgan Godvin, Levi Cecil, Adam Koncsol, Caitlin A. Molina, Megan Grabill, Ruby Romero, Elham Jalayer, Naomi Villanueva, Oscar Arellano, Amanda Cowan, Russell G. Buhr, Honora Englander, Joseph R. Friedman, Philippe Bourgois, Chelsea L. Shover medRxiv 2026.11.13.26367858; doi: https://doi.org/10.64898/2026.11.13.26367858 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.13.26367858v1%26text%3DFentanyl%2520dabbing%2520with%2520cannabis%2520retail%2520equipment%253A%2520an%2520ethnographic%2520and%2520drug-checking%2520study "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.13.26367858v1%26t%3DFentanyl%2520dabbing%2520with%2520cannabis%2520retail%2520equipment%253A%2520an%2520ethnographic%2520and%2520drug-checking%2520study "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.13.26367858v1%26title%3DFentanyl%2520dabbing%2520with%2520cannabis%2520retail%2520equipment%253A%2520an%2520ethnographic%2520and%2520drug-checking%2520study%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.13.26367858v1%26title%3DFentanyl%2520dabbing%2520with%2520cannabis%2520reta
## Related Clinical Research

- [Clinical features and hospital management of snakebite in Northern Uganda: multi-facility review](https://medichelpline.com/clinical-feed/plos-one-15-clinical-features-first-aid-practices-and-hospital-management-of-snakebites-in.md)
- [Ransomware in US Health Care: Faster Exploitation and Smaller Breaches, 2016–2026](https://medichelpline.com/clinical-feed/medrxiv-6-the-shrinking-grace-period-and-the-downsizing-of-ransomware-victims.md)
- [MIF inhibitor ISO-1 reduces ischemia–reperfusion injury in rat DCD liver transplantation](https://medichelpline.com/clinical-feed/plos-one-14-mif-inhibitor-iso-1-attenuates-ischemia-reperfusion-injury-in-a-rat-model-of.md)
- [Renal Consequences of Inhaled Nitric Oxide in Critically Ill Patients](https://medichelpline.com/clinical-feed/pubmed-43061996.md) (DOI: 10.4103/mgr.MEDGASRES-D-26-00116)
- [PDK4 and Acute Kidney Injury: Metabolic Control of AKI and the AKI‑to‑CKD Transition](https://medichelpline.com/clinical-feed/pubmed-43059392.md) (DOI: 10.3892/mmr.2026.14075)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.